Juno Tanks 30% Pre-Market After FDA Halts Cancer Trial

The trial was halted after two patient deaths following the addition of a new preconditioning drug to the trial regimen.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.